Acrivon Share Price

Acrivon Share Price

NASDAQ: ACRV | Micro Cap | Healthcare
$1.55
+$0.13 (8.77%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Acrivon Stock Performance

Open
$1.51
Prev. Close
$1.43
Circuit Range
N/A
Day Range
$1.51 - $1.60
Year Range
$1.27 - $3.54
Volume
28,707
Average Traded
$1.56

Acrivon Share Price Today

As of 19 November 2026, Acrivon Therapeutics, Inc.'s share price is $1.55. The stock opened at $1.51, compared to its previous close of $1.43. During today's trading session, Acrivon Therapeutics, Inc.'s share price traded between $1.51 and $1.60, with an average price of $1.56. Over the past 52 weeks, the stock has recorded a high of $3.54 and a low of $1.27. In terms of performance, Acrivon Therapeutics, Inc.'s share price has declined by 4.02% over the last six months and is down 34.60% on a year-on-year basis.

Acrivon Share Price Chart

Line chart of the Acrivon price trend over the selected period. The price rose overall, ranging from 1.48 to 1.60, ending at 1.55.
$1.51$1.60
L
Show Current Price
H

Acrivon Stock Fundamentals & Key Indicators

Market Cap
$59.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.73
Revenue (TTM)
$0.00
Return On Equity (TTM)
-85.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.48%

Acrivon Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.23-$18.99-$19.04-$17.96
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-4.17%-0.26%5.67%

Acrivon Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$31.17-$60.39-$80.56-$77.91
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-93.74%-33.40%3.29%

Acrivon Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets9.2714.968.5749.13
Current Assets120.45181.63129.69132.1
Total Assets129.72196.59138.27181.23
Non Current Liabilities1.542.593.774.24
Current Liabilities15.6617.2113.36.52
Total Liabilities17.219.817.0710.75
Shareholders' Equity112.52176.79121.2170.48

Acrivon Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-63.67-65.67-42.64-30.12
Investing66.1-51.7750.72-141.68
Financing-0.75121.03-1.55101.71

About Acrivon

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Acrivon Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.66
$1.56
-6.59%
Oct 2026
$2.06
$1.67
-18.54%
Sep 2026
$2.04
$2.05
-5.09%
Aug 2026
$1.49
$2.16
+43.05%
Jul 2026
$1.77
$1.51
-15.17%
Jun 2026
$1.58
$1.78
+10.22%
May 2026
$1.88
$1.61
-12.70%
Apr 2026
$1.46
$1.85
+32.14%
Mar 2026
$1.48
$1.40
-7.59%
Feb 2026
$1.75
$1.51
-15.13%
Jan 2026
$2.39
$1.78
-26.09%
Dec 2025
$2.37
$2.42
+1.90%

Acrivon Share Price FAQs